Comprehensive autophagy research requires integrated analysis of autophagy initiation, autophagic flux, lysosomal function, selective organelle clearance, and metabolic signaling networks to understand cellular homeostasis, aging biology, and disease progression.

We provide an integrated research toolkit — from autophagy core regulators to dynamic flux monitoring assays — enabling accurate investigation of autophagic activity and biological function.

• Key Target Highlights

Core Molecular Targets in Autophagy Research

• Key research trend:

Modern autophagy research is increasingly moving beyond measuring single markers such as LC3-II accumulation toward comprehensive evaluation of autophagic flux, lysosomal competence, selective autophagy pathways, metabolic regulation, and organelle quality control. Emerging studies emphasize that autophagy functions as an adaptive signaling network integrating mTOR/AMPK nutrient sensing, mitochondrial homeostasis, immune regulation, and aging-associated stress responses, providing new opportunities for therapeutic intervention.

• Recommended Autophagy Marker Strategy

Multi-Level Validation Framework

Core Autophagy Validation Strategy

"Golden Pair" Concept for Pathway Confirmation

• Competitive Technology Landscape

Autophagy Research Workflow

An integrated autophagy research workflow combining molecular validation, functional assays, advanced imaging, multi-omics profiling, and single-cell analysis to comprehensively characterize autophagy dynamics, mechanisms, and biological functions across multiple levels of biological complexity.

• Pathway Overview

Autophagy is a conserved cellular recycling process that maintains homeostasis through degradation of damaged proteins and organelles. The ULK1 initiation complex, Beclin-1/VPS34 complex, ATG proteins, and lysosomal pathways coordinate autophagosome formation and cargo degradation. Autophagy regulates metabolism, stress adaptation, immunity, aging, and disease progression.

Autophagy control by cellular signaling (PMID: 41086756)
 

• Recommended Experimental Validation Workflow

• Featured Research Application Examples

• Frequently Asked Questions

Q1. Which biomarkers should I use to accurately assess autophagy?

No single biomarker is sufficient. A comprehensive evaluation should combine LC3-I/II for autophagosome formation, SQSTM1/p62 for cargo degradation, Beclin-1 and ATG proteins for autophagy initiation, together with lysosomal markers such as LAMP1/2 to assess autophagosome maturation.

.Q2. How can I distinguish autophagy induction from impaired autophagic degradation?

Increased LC3-II alone does not necessarily indicate enhanced autophagy. Autophagic flux assays, combining lysosomal inhibitors (e.g., Bafilomycin A1 or Chloroquine) with LC3-II and p62 analysis, are considered the gold standard for differentiating increased autophagy from blocked lysosomal degradation.

Q3. Which experimental approaches provide the most reliable assessment of autophagy?

Robust autophagy studies integrate orthogonal methodologies, including Western blotting, immunofluorescence, autophagic flux assays, live-cell imaging, electron microscopy, and genetic perturbation. Combining complementary approaches minimizes experimental bias and strengthens biological conclusions.

Q4. What are the most common pitfalls in autophagy research?

Common pitfalls include interpreting LC3-II accumulation as increased autophagy without flux analysis, relying on a single biomarker, using insufficient experimental controls, and failing to validate antibody specificity. Multiple independent readouts and appropriate positive and negative controls are essential for accurate interpretation.

Q5. How can autophagy be comprehensively characterized across biological systems?

Modern autophagy research integrates protein validation, functional assays, high-resolution imaging, proteomics, metabolomics, and single-cell/spatial omics to reveal pathway activation, autophagic dynamics, functional remodeling, and cellular heterogeneity from molecular to tissue levels.

• Key References

1.  Radulovic M., Yang C., Stenmark H. (2025).Lysosomal membrane homeostasis and its importance in physiology and disease.Nature Reviews Molecular Cell Biology. 27:71–87.

2. Nixon R.A., Rubinsztein D.C. (2024).Mechanisms of autophagy–lysosome dysfunction in neurodegenerative diseases.Nature Reviews Molecular Cell Biology. 25(12):926–946.

3. Settembre C., Perera R.M. (2024).Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology.Nature Reviews Molecular Cell Biology. 25:223–245.

4. Wang L., Klionsky D.J., Shen H.-M. (2023). The emerging mechanisms and functions of microautophagy. Nature Reviews Molecular Cell Biology. 24:186–203

5. Gross A.S., Ghillebert R., Schuetter M., et al. (2024). A metabolite sensor subunit of the Atg1/ULK complex regulates selective autophagy. Nature Cell Biology. 26.

6. Nakatogawa H. (2020). Mechanisms governing autophagosome biogenesis. Nature Reviews Molecular Cell Biology. 21:439–458.

7. Vargas J.N.S., Hamasaki M., Yoshimori T. (2022). The mechanisms and roles of selective autophagy in mammals. Nature Reviews Molecular Cell Biology. 24:167–185.

8. Kaur J., Debnath J. (2015). Autophagy at the crossroads of catabolism and anabolism. Nature Reviews Molecular Cell Biology. 16:461–472.

9. Klionsky D.J., Abdel-Aziz A.K., Abdelfatah S., et al. (2021). Guidelines for the use and interpretation of assays for monitoring autophagy (5th Edition). Autophagy.